Milestone Pharmaceuticals’ CARDAMYST: A Promising Buy with FDA Decision and Phase 3 Trial on Horizon
In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research ...
Welcome to the Room Spray Renaissance
Gone are the days of a quick Febreze spritz before a dinner party, and the luxury candle’s time in the limelight might be ...
Business Insider2d
Milestone Pharmaceuticals (MIST) Gets a Buy from Piper Sandler
It designs and develops a rapid-onset nasal spray with Etripamil. The company was founded by Philippe Douville and Philippe Lamarre in 2005 and is headquartered in Montreal, Canada. Read More on MIST: ...